Health Canada / Santé Canada Pharmacological Testing for Novel Opioids, Stimulants, and Synthetic Cannabinoids RFP
Posted
Aug 20, 2026
Sep 18, 2026
This RFP is for pharmacological testing services for novel opioids, stimulants, and synthetic cannabinoids, across three distinct streams: in vitro testing of emerging opioids at the Mu Opioid Receptor (MOR), in vitro testing of novel synthetic cannabinoids, and in vitro testing of stimulant compounds.
